3003新葡的京集团
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2014.11.20
2014年第四次临时股东大会的法律意见书
2014.11.04
关于公司使用自有资金对TPG BIOTECHNOLOGY PARTNERS IV,L.P.进行投资的公告
2014.11.04
第三届董事会第五次会议决议公告
2014.10.30
关于会计政策变更的公告
2014.10.30
第三届董事会第四次会议决议公告
2014.10.30
第三届监事会第四次会议决议公告
2014.10.30
关于增加自有资金购买银行保本理财产品额度的公告
2014.10.30
关于开展利率掉期和远期外汇交易的公告
2014.10.30
关于公司向花旗银行(中国)深圳分行申请授信的公告
2014.10.30
关于召开2014年第四次临时股东大会的通知
第一页
上一页
107
108
109
110
111
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright © 2024 Hepalink Group. All Rights Reserved.